Zhang F, Slungaard A, Vercellotti G M, Iadecola C
Laboratory of Cerebrovascular Biology and Stroke, Department of Neurology, University of Minnesota Medical School, Minnesota 55455, USA.
Am J Physiol. 1998 Jun;274(6):R1704-11. doi: 10.1152/ajpregu.1998.274.6.R1704.
Recent evidence indicates that elevated plasma levels of homocysteine are a risk factor for ischemic cerebrovascular diseases. However, little is known about cerebrovascular effects of homocysteine. Homocysteine could impair cerebrovascular function by metal-catalyzed production of activated oxygen species. We studied whether homocysteine, in the presence of Cu2+, alters reactivity of cerebral circulation and, if so, whether this effect depends on O-2 generation. In halothane-anesthetized rats the parietal cortex was exposed and superfused with Ringer solution. Cerebrocortical blood flow (CBF) was monitored by a laser-Doppler probe. With Ringer solution superfusion, CBF increased with hypercapnia (+134 +/- 7%; PCO2 = 50-60 mmHg) and topical application of 10 microM ACh (+35 +/- 3%), the NO donor S-nitroso-N-acetylpenicillamine (SNAP, 500 microM; +66 +/- 6%), or 1 mM papaverine (+100 +/- 6%; n = 5). Superfusion with 40 microM Cu2+ alone did not perturb resting CBF or responses to hypercapnia, ACh, SNAP, or papaverine (P > 0.05, n = 5). However, superfusion of homocysteine-Cu2+ reduced resting CBF (-28 +/- 4%) and attenuated (P < 0.05) responses to hypercapnia (-31 +/- 9%), ACh (-73 +/- 6%), or SNAP (-48 +/- 4%), but not papaverine. The effect was observed only at 1 mM homocysteine. Cerebrovascular effects of homocysteine-Cu2+ were prevented by coadministration of superoxide dismutase (SOD; 1,000 U/ml; n = 5). SOD alone did not affect resting CBF or CBF reactivity (n = 5). The observation that homocysteine-Cu2+ attenuates the response to hypercapnia, ACh, and SNAP, but not the NO-independent vasodilator papaverine, suggests that homocysteine-Cu2+ selectively impairs NO-related cerebrovascular responses. The fact that SOD prevents such impairment indicates that the effect of homocysteine is O-2 dependent. The data support the conclusion that O-2, generated by the reaction of homocysteine with Cu2+, inhibits NO-related cerebrovascular responses by scavenging NO, perhaps through peroxynitrite formation. O-2-mediated scavenging of NO might be one of the mechanisms by which hyperhomocysteinemia predisposes to cerebrovascular diseases.
最近的证据表明,血浆中同型半胱氨酸水平升高是缺血性脑血管疾病的一个危险因素。然而,关于同型半胱氨酸对脑血管的影响却知之甚少。同型半胱氨酸可通过金属催化产生活性氧而损害脑血管功能。我们研究了在有Cu2+存在的情况下,同型半胱氨酸是否会改变脑循环的反应性,如果是,这种效应是否依赖于O-2的生成。在氟烷麻醉的大鼠中,暴露顶叶皮质并用林格氏液进行灌流。用激光多普勒探头监测脑皮质血流(CBF)。在林格氏液灌流时,CBF随高碳酸血症(增加134±7%;PCO2 = 50 - 60 mmHg)以及局部应用10 μM乙酰胆碱(ACh,增加35±3%)、NO供体S-亚硝基-N-乙酰青霉胺(SNAP,500 μM,增加66±6%)或1 mM罂粟碱(增加100±6%;n = 5)而增加。单独用40 μM Cu2+灌流不会干扰静息CBF或对高碳酸血症、ACh、SNAP或罂粟碱的反应(P > 0.05,n = 5)。然而,同型半胱氨酸 - Cu2+灌流降低了静息CBF(-28±4%),并减弱了(P < 0.05)对高碳酸血症(-31±9%)、ACh(-73±6%)或SNAP(-48±4%)的反应,但对罂粟碱的反应未减弱。仅在1 mM同型半胱氨酸时观察到这种效应。同型半胱氨酸 - Cu2+的脑血管效应可通过同时给予超氧化物歧化酶(SOD;1000 U/ml;n = 5)而被预防。单独的SOD不影响静息CBF或CBF反应性(n = 5)。同型半胱氨酸 - Cu2+减弱了对高碳酸血症、ACh和SNAP的反应,但未减弱对不依赖NO的血管扩张剂罂粟碱的反应,这一观察结果表明同型半胱氨酸 - Cu2+选择性地损害了与NO相关的脑血管反应。SOD可预防这种损害这一事实表明同型半胱氨酸的作用是O-2依赖性的。这些数据支持这样的结论,即同型半胱氨酸与Cu2+反应生成的O-2通过清除NO(可能是通过形成过氧亚硝酸盐)来抑制与NO相关的脑血管反应。O-2介导的NO清除可能是高同型半胱氨酸血症易患脑血管疾病的机制之一。